News | September 10, 2008

Preclinical Imaging Seen from ‘New Point of View’

September 11, 2008 - For the fifth year, Siemens Healthcare ( presented the “New Point of View” Preclinical Image of the Year Awards, designed to demonstrate how Siemens preclinical imaging systems help researchers improve the quality of imaging and overall research, at the Siemens Preclinical User’s Group Meeting, held in Nice, France.

The awards are intended to honor pioneering researchers and their contributions. Advanced new imaging solutions and multimodal systems are shedding new light on dissecting disease processes and unlocking potential new treatments. Images were acquired on Siemens preclinical imaging systems: the Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

“The ‘New Point of View’ image competition illustrates the breadth and novelty of applications for which preclinical imaging technologies are being used. The potential for breakthrough discoveries will eventually have impact in the clinical environment through translational research,” said Kirti Patel, vice president, Preclinical Solutions, Siemens Healthcare. “Our focus is to provide high-quality preclinical imaging tools and workflow solutions that will speed the discovery process for our customers.”

The “New Point of View” competition was open to anyone with a Siemens preclinical scanner. Researchers were allowed to use any type of radiopharmaceutical tracer or any other contrast material. Entries were judged on scientific merit, the type of information gleaned from the images and the overall quality of the images. All images were judged by a panel of industry experts and members of Siemens Preclinical Research and Development team.

Inveon Image of the Year Winner
“4-Dimensional Dosimetry of 131I-NM404 Using µPET/CT and Pinnacle,” acquired by J. Grudzinski, M. Christensen, W. Tome, M. Bahl and J. Weichert, University of Wisconsin.

Multimodality Image of the Year Winner
“Quantification of PECAM-1 Expression in Regions of Myocardial Infarction Using MR-PET,” acquired by L. Locke, Z. Yang, Y. Zhang, R. Tian, B. Kundu, J. Linden, S. Berr and D. Pan, University of Virginia.

Most Innovative Image of the Year Winner
“Kit-like” labeling of PET tracers: 18F-SiFA for bloodpool imaging of transplanted rat hearts,” acquired by G. Boening, University of Munich.

Drug Discovery Image of the Year Winner
“P-glycoprotein modulation at the rat blood-brain barrier studied with (R)-[11C]-Verapamil PET,” acquired by C. Kuntner, J. Bankstahl, A. Abrahim, R. Karch, J. Stanek, T. Wanek, M. Zsebedics, W. Wadsak, K. Kletter, M. Müller, W. Löscher, O. Langer, Austrian Research Centers GmbH-ARC.

For more information:

Related Content

Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...